University of California San Francisco

Kathy Giacomini, PhD

Kathy Giacomini, PhD
Kathy Giacomini, PhD

Professor, Bioengineering
Co-Director UCSF-Stanford Center of Excellence in Regulatory Sciences and Innovation

Address

513 Parnassus Avenue MSB, #126
San Francisco, CA 94143
United States

Email: [email protected]

ORCID: 0000-0001-8041-5430

Awards & Honors

Award Conferred By Date
Gavin Herbert Award Chapman University School of Pharmacy 2025
Elected Member American Academy of Arts and Sciences 2024
Elected Fellow American Society for Clinical Pharmacology and Experimental Therapeutics 2024
Oscar B. Hunt Career Award in Therapeutics American Society for Clinical Pharmacology and Experimental Therapeutics 2024
Reynold Spector Award in Clinical Pharmacology American Society for Pharmacology and Experimental Therapeutics 2023
Willis G. Gregory Memorial Award University of Buffalo School of Pharmacy & Pharmaceutical Sciences 2023
Distinguished Pharmaceutical Scientist Award American Association of Pharmaceutical Scientists 2021
B.B. Brodie Award American Society of Pharmacology and Experimental Therapeutics 2020
Volwiler Research Achievement Award American Association of Colleges of Pharmacy 2018
Scheele Award Swedish Academy of Pharmaceutical Scientists 2011
Therapeutic Frontiers Lecture Award Therapeutic Frontiers Lecture Award 2010
Rawls-Palmer Progress in Medicine Award American Society for Clinical Pharmacology and Therapeutics 2009
Outstanding Mentor Award Postdoctoral Scholars Association, University of California, San Francisco 2009
Invitation Fellowship Program for Research in Japan Japan Society for the Promotion of Science 2008
International Woman Scientist Award Academy of Pharmaceutical Sciences and Technology, Japan 2007
Research Achievement Award Pharmaceutical Sciences World Congress 2007
Distinguished Scientist Award in Drug Metabolism American Association of Pharmaceutical Scientists 2006
Elected Member National Academy of Medicine 2006
Paul Dawson Biotechnology Award American Association of Colleges of Pharmacy 2005
Distinguished Gerhard Levy Lectureship State University of New York at Buffalo 2002
Distinguished Bill Abram's Lectureship U.S. Food and Drug Administration 2002
Honored Celebrating Women Faculty University of California, San Francisco 2002
Guttman Lecturer University of Kentucky 2000
Scientist of the Year International Pharmaceutical Federation (FIP) 1999
Recognition Award for Distinguished Achievement of a Filipino at UCSF University of California, San Francisco 1999
Chancellor's Award for the Advancement of Women University of California, San Francisco 1997
Martin Luther King, Jr. Award for the Advancement of Minorities University of California, San Francisco 1994
Fogarty International Fellowship National Institutes of Health 1992
Leon Goldberg Young Investigator Award American Society for Clinical Pharmacology and Therapeutics 1990

Grants and Funding

  • Transporter Elucidation Center at the University of California, San Francisco | NIH | 2023-09-19 - 2028-06-30 | Role: Co-Investigator
  • Characterizing the physiological and pharmacological roles of SLC22A24 | NIH | 2021-04-01 - 2025-03-31 | Role: Principal Investigator
  • Discovery of Pharmacogenomic Biomarkers for OATP1B1 and OATP1B3 | NIH | 2015-09-25 - 2024-07-31 | Role: Principal Investigator
  • UCSF-Stanford Center of Excellence in Regulatory Science and Innovation | NIH | 2016-09-15 - 2023-08-31 | Role: Principal Investigator
  • PGRN Administrative Coordination Hub, ACH (PGRN) | NIH/NIGMS | 2015-07-15 - 2020-06-30 | Role: Principal Investigator
  • Role of ABCG2 in the disposition and anti-hyperuricemic effects of allopurinol | NIH | 2014-09-20 - 2018-07-31 | Role: Principal Investigator
  • UCSF-Stanford Center of Excellence in Regulatory Science and Innovation | NIH | 2014-04-15 - 2017-03-31 | Role: Principal Investigator
  • Center for Structure of Membrane Proteins | NIH | 2010-09-30 - 2016-06-30 | Role: Co-Investigator
  • Pharmacogenomics of Membrane Transporters | NIH | 2000-04-01 - 2015-06-30 | Role: Principal Investigator
  • A Comprehensive Platform for Transporter Mediated Drug-Drug Interaction Studies | NIH | 2009-02-01 - 2013-09-30 | Role: Principal Investigator
  • Resource for Biocomputing, Visualization, and Informatics | NIH/NCRR | 1976-06-01 - 2012-09-14 | Role: Co-Investigator
  • Cellular Mechanisms of Drug Elimination | NIH | 1986-04-04 - 2012-05-31 | Role: Principal Investigator
  • Pharmacogenetics of Membrane Transporters | NIH | 2000-04-01 - 2010-07-14 | Role: Principal Investigator
  • General Clinical Research Center | NIH | 1974-12-01 - 2009-03-31 | Role: Co-Investigator
  • General Clinical Research Center | NIH | 1974-10-01 - 2007-11-30 | Role: Co-Investigator
  • CELLULAR MECHANISMS OF DRUG TRANSPORT IN CHOROID PLEXUS | NIH | 1991-01-01 - 2003-12-31 | Role: Principal Investigator
  • MOLECULAR BASIS OF DRUG TRANSPORT IN THE INTESTINE | NIH | 1997-08-01 - 2001-07-31 | Role: Principal Investigator
  • PHARMACOKINETICS/PHARMACODYNAMICS | NIH | 1979-08-01 - 1998-07-31 | Role: Co-Investigator
  • MOLECULAR MECHANISMS OF DRUG TRANSPORT | NIH | 1992-01-01 - | Role: Principal Investigator
  • STEREOSELECTIVE PHARMACOKINETICS OF DRUGS IN THE KIDNEY | NIH | 1983-03-01 - 1989-06-30 | Role: Principal Investigator

Publications

MOST RECENT PUBLICATIONS FROM A TOTAL OF 10
  1. Proteomic profiling reveals age-related changes in transporter proteins in the human blood-brain barrier.
    Zhou X, Azimi M, Handin N, Riselli A, Vora B, Chun E, Dang Z, Huang E, Yee SW, Artursson P, Giacomini KM| | PubMed
  2. Innovations in Clinical Pharmacology: Shaping the Future of Evidence Generation in Research, Development, and Utilization of Medicines.
    Venkatakrishnan K, Joshi A, Gerding A, Giacomini KM, van der Graaf PH| | PubMed
  3. Seasons of Growth: Reflections on the CPT Editor-in-Training Program.
    van Hoogdalem MW, Dunn A, Mehanna M, Wen YF, Choi YS, Brown KE, Minichmayr IK, Smith DM, Cicali EJ, Shahin MH, Giacomini KM, van der Graaf PH| | PubMed
  4. What is History? An Echo of the Past in the Future; A Reflex From the Future on the Past.
    Giacomini KM, van der Graaf PH| | PubMed
  5. High Virologic Suppression and Favorable Profiles of Two-Drug Antiretroviral Regimens in Africa: A Systematic Review of Current Evidence.
    Akpa PA, Isah A, Cocohoba J, Giacomini KM, Oni-Orisan A, Ugochukwu EJ, Ngige AP, Agbo C, Nwachuya CA| | PubMed
  6. Development and evaluation of a lightweight large language model chatbot for medication enquiry.
    Elangovan K, Ong JCL, Jin L, Seng BJJ, Kwan YH, Ng LS, Zhong RJ, Ma JKL, Ke YH, Liu N, Giacomini KM, Ting DSW| | PubMed
  7. Leading the Way: Multi-Drug Resistance Protein (MDR1) and Clinical Pharmacology-Commentary on Kim et al.
    Giacomini KM| | PubMed
  8. Predicting OCT2/MATEs-Mediated Drug Interactions in Healthy Volunteers and Patients with Chronic Kidney Disease: Insights from Extended Clearance Concept, Endogenous Biomarkers, and In Vitro Inhibition Studies (Perspectives from the International Transpor
    Asano S, Galetin A, Tomita Y, Giacomini KM, Chu X, Yang X, Nakamura T, Kusuhara H, Sugiyama Y| | PubMed
  9. Drug Interactions Brewing.
    van Hoogdalem MW, Giacomini KM| | PubMed
  10. MRI Provides New Insights Into the Pharmacologic Mechanism of Bisacodyl: A Blueprint for Understanding Intestinal Drug Mechanisms.
    Giacomini KM| | PubMed